Maneb and paraquat-mediated neurotoxicity: Involvement of peroxiredoxin/thioredoxin system

Toxicological Sciences

Volumn 121, Issue 2, 2011, Pages 368-375

  Roede, James R ^a   Hansen, Jason M ^b   Go, Young Mi ^a   Jones, Dean P ^a  

^a Division of Pulmonary   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Maneb; Nrf2; Paraquat; Parkinson's disease; Peroxiredoxin; Thioredoxin

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; MANEB; PARAQUAT; PEROXIREDOXIN 3; REACTIVE OXYGEN METABOLITE; THIOREDOXIN 2; TRANSCRIPTION FACTOR NRF2;

ARTICLE; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRION; NEUROTOXICITY; OXIDATION; OXIDATIVE STRESS;

EID: 79957827273     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr058     Document Type: Article

References (35)

1. Arner, E. S., and Holmgren, A. (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109.
2. Barlow, B. K., Thiruchelvam, M. J., Bennice, L., Cory-Slechta, D. A., Ballatori, N., and Richfield, E. K. (2003). Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates. J. Neurochem. 85, 1075-1086.
3. Castello, P. R., Drechsel, D. A., and Patel, M. (2007). Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J. Biol. Chem. 282, 14186-14193.
4. Chen, X., Zhong, Z., Xu, Z., Chen, L., and Wang, Y. (2010). 2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy. Free Radic. Res. 44, 587-604.
5. Chen, Y., Yu, M., Jones, D. P., Greenamyre, J. T., and Cai, J. (2006). Protection against oxidant-induced apoptosis by mitochondrial thioredoxin in SH-SY5Y neuroblastoma cells. Toxicol. Appl. Pharmacol. 216, 256-262.
6. Costello, S., Cockburn, M., Bronstein, J., Zhang, X., and Ritz, B. (2009). Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am. J. Epidemiol. 169, 919-926.
7. Cox, A. G., Peskin, A. V., Paton, L. N., Winterbourn, C. C., and Hampton, M. B. (2009). Redox potential and peroxide reactivity of human peroxiredoxin 3. Biochemistry, 48, 6495-6501.
8. de Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J., Drukarch, B., Hoozemans, J., and van Horssen, J. (2008). Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic. Biol. Med. 45, 1375-1383.
9. Dias, P. J., Teixeira, M. C., Telo, J. P., and Sa-Correia, I. (2010). Insights into the mechanisms of toxicity and tolerance to the agricultural fungicide mancozeb in yeast, as suggested by a chemogenomic approach. OMICS, 14, 211-227.
10. Domico, L. M., Zeevalk, G. D., Bernard, L. P., and Cooper, K. R. (2006). Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction. Neurotoxicology, 27, 816-825.
11. Drechsel, D. A., and Patel, M. (2008). Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic. Biol. Med. 44, 1873-1886.
12. Drechsel, D. A., and Patel, M. (2010). Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system. J. Biol. Chem. 285, 27850-27858.
13. Franco, R., Li, S., Rodriguez-Rocha, H., Burns, M., and Panayiotidis, M. I. (2010). Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson's disease. Chem. Biol. Interact. 188, 289-300.
14. Hancock, D. B., Martin, E. R., Mayhew, G. M., Stajich, J. M., Jewett, R., Stacy, M. A., Scott, B. L., Vance, J. M., and Scott, W. K. (2008). Pesticide exposure and risk of Parkinson's disease: a family-based case-control study. BMC Neurol. 8, 6.
15. Hansen, J. M., Watson, W. H., and Jones, D. P. (2004). Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. 82, 308-317.
16. He, M., Cai, J., Go, Y. M., Johnson, J. M., Martin, W. D., Hansen, J. M., and Jones, D. P. (2008). Identification of thioredoxin-2 as a regulator of the mitochondrial permeability transition. Toxicol. Sci. 105, 44-50.
17. Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K., and Yodoi, J. (1997). AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. U S A. 94, 3633-3638.
18. Johnson, J. A., Johnson, D. A., Kraft, A. D., Calkins, M. J., Jakel, R. J., Vargas, M. R., and Chen, P. C. (2008). The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N Y Acad. Sci. 1147, 61-69.
19. Jones, D. P., Carlson, J. L., Samiec, P. S., Sternberg, P., Jr., Mody, V. C., Jr., Reed, R. L., and Brown, L. A. (1998). Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta. 275, 175-184.
20. Jones, D. P., and Go, Y. M. (2010). Redox compartmentation of cellular stress. Diabetes Obes. Metab. 12(Suppl. 2), 116L-125.
21. Martin, H. L., and Teismann, P. (2009). Glutathione-a review on its role and significance in Parkinson's disease. FASEB J. 23, 3263-3272.
22. Matthews, J. R., Wakasugi, N., Virelizier, J. L., Yodoi, J., and Hay, R. T. (1992). Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20, 3821-3830.
23. Nonn, L., Williams, R. R., Erickson, R. P., and Powis, G. (2003). The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23, 916-922.
24. Oyama, Y., Hayashi, A., Ueha, T., and Maekawa, K. (1994). Characterization of 2',7'-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide. Brain Res. 635, 113-117.
25. Requejo, R., Chouchani, E. T., Hurd, T. R., Menger, K. E., Hampton, M. B., and Murphy, M. P. (2010). Measuring mitochondrial protein thiol redox state. Methods Enzymol. 474, 123-147.
26. Rhee, S. G., Chae, H. Z., and Kim, K. (2005). Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38, 1543-1552.
27. Rhee, S. G., Chang, T. S., Jeong, W., and Kang, D. (2010). Methods for detection and measurement of hydrogen peroxide inside and outside of cells. Mol. Cells 29, 539-549.
28. Ritz, B., and Yu, F. (2000). Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int. J. Epidemiol. 29, 323-329.
29. Thiruchelvam, M., Brockel, B. J., Richfield, E. K., Baggs, R. B., and Cory-Slechta, D. A. (2000). Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res. 873, 225-234.
30. Thiruchelvam, M., McCormack, A., Richfield, E. K., Baggs, R. B., Tank, A. W., Di Monte, D. A., and Cory-Slechta, D. A. (2003). Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur. J. Neurosci. 18, 589-600.
31. Thiruchelvam, M., Prokopenko, O., Cory-Slechta, D. A., Buckley, B., and Mirochnitchenko, O. (2005). Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J. Biol. Chem. 280, 22530-22539.
32. Watson, W. H., Pohl, J., Montfort, W. R., Stuchlik, O., Reed, M. S., Powis, G., and Jones, D. P. (2003). Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J. Biol. Chem. 278, 33408-33415.
33. Wood, Z. A., Schroder, E., Robin Harris, J., and Poole, L. B. (2003). Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40.
34. Zhang, D. D. (2006). Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38, 769-789.
35. Zhang, J., Fitsanakis, V. A., Gu, G., Jing, D., Ao, M., Amarnath, V., and Montine, T. J. (2003). Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J. Neurochem. 84, 336-346.